These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32039532)

  • 1. Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation.
    Mito R; Matsubara E; Komohara Y; Shinchi Y; Sato K; Yoshii D; Ohnishi K; Fujiwara Y; Tomita Y; Ikeda K; Sakagami T; Suzuki M
    Pathol Int; 2020 May; 70(5):287-294. PubMed ID: 32039532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of EpCAM and TROP2 expression in non-small cell lung cancer.
    Pak MG; Shin DH; Lee CH; Lee MK
    World J Surg Oncol; 2012 Apr; 10():53. PubMed ID: 22482828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells.
    Li Z; Jiang X; Zhang W
    Biochem Biophys Res Commun; 2016 Jan; 470(1):197-204. PubMed ID: 26773504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.
    Inamura K; Yokouchi Y; Kobayashi M; Ninomiya H; Sakakibara R; Subat S; Nagano H; Nomura K; Okumura S; Shibutani T; Ishikawa Y
    Oncotarget; 2017 Apr; 8(17):28725-28735. PubMed ID: 28404926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated calcium signal transducer 2 regulates neovascularization of non-small-cell lung cancer via activating ERK1/2 signaling pathway.
    Guo X; Zhu X; Zhao L; Li X; Cheng D; Feng K
    Tumour Biol; 2017 Mar; 39(3):1010428317694324. PubMed ID: 28345466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.
    Fong D; Spizzo G; Gostner JM; Gastl G; Moser P; Krammel C; Gerhard S; Rasse M; Laimer K
    Mod Pathol; 2008 Feb; 21(2):186-91. PubMed ID: 18084248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis.
    Foersch S; Schmitt M; Litmeyer AS; Tschurtschenthaler M; Gress T; Bartsch DK; Pfarr N; Steiger K; Denkert C; Jesinghaus M
    J Pathol Clin Res; 2024 Sep; 10(5):e12394. PubMed ID: 39177576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of Trop2 on non-small-cell lung cancer and normal cell membranes revealed by super-resolution fluorescence imaging.
    Fu Y; Jing Y; Gao J; Li Z; Wang H; Cai M; Tong T
    Talanta; 2020 Jan; 207():120312. PubMed ID: 31594569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of TROP2 in human nasopharyngeal carcinoma.
    Guan GF; Zhang DJ; Wen LJ; Yu DJ; Zhao Y; Zhu L; Guo YY; Zheng Y
    Int J Clin Exp Pathol; 2015; 8(9):10995-1004. PubMed ID: 26617817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Rise of the TROP2-Targeting Agents in NSCLC: New Options on the Horizon.
    Ahmed Y; Berenguer-Pina JJ; Mahgoub T
    Oncology; 2021; 99(10):673-680. PubMed ID: 34280931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer.
    Jeon Y; Jo U; Hong J; Gong G; Lee HJ
    BMC Cancer; 2022 Sep; 22(1):1014. PubMed ID: 36153494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.
    Lin JC; Wu YY; Wu JY; Lin TC; Wu CT; Chang YL; Jou YS; Hong TM; Yang PC
    EMBO Mol Med; 2012 Jun; 4(6):472-85. PubMed ID: 22419550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer.
    Zhu WY; Hu XF; Fang KX; Kong QQ; Cui R; Li HF; He JY; Zhang YK; Le HB
    Histol Histopathol; 2019 Nov; 34(11):1269-1278. PubMed ID: 31062864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis.
    Tanegashima K; Tanaka Y; Ito T; Oda Y; Nakahara T
    Exp Dermatol; 2024 Oct; 33(10):e15196. PubMed ID: 39422290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
    Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
    BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma.
    Nakashima K; Shimada H; Ochiai T; Kuboshima M; Kuroiwa N; Okazumi S; Matsubara H; Nomura F; Takiguchi M; Hiwasa T
    Int J Cancer; 2004 Dec; 112(6):1029-35. PubMed ID: 15386348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts.
    Bahlinger V; Branz A; Strissel PL; Strick R; Lange F; Geppert CI; Klümper N; Hölzel M; Wach S; Taubert H; Sikic D; Wullich B; Angeloni M; Ferrazzi F; Diehl L; Kovalenko M; Elboudwarej E; Jürgensmeier JM; Hartmann A; Eckstein M
    Histopathology; 2024 Apr; 84(5):863-876. PubMed ID: 38196202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
    Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
    Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.